Allgens Historical Income Statement

688613 Stock

17.48 0.05 0.29%

Historical analysis of Allgens Medical income statement accounts such as Interest Expense of 1.7 M, Selling General Administrative of 92.6 M or Selling And Marketing Expenses of 19.1 M can show how well Allgens Medical Technology performed in making a profits. Evaluating Allgens Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Allgens Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Allgens Medical Tech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Allgens Medical Tech is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allgens Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Allgens Income Statement Analysis

Allgens Medical Tech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Allgens Medical shareholders. The income statement also shows Allgens investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Allgens Medical Income Statement Chart

At present, Allgens Medical's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 92.6 M, whereas Interest Expense is forecasted to decline to about 1.7 M.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit

Total Revenue

Total revenue comprises all receipts Allgens Medical Tech generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Allgens Medical Technology minus its cost of goods sold. It is profit before Allgens Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Allgens Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Allgens Medical Tech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allgens Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Gross Profit	201.5M	204.5M	187.2M	167.0M
Total Revenue	236.1M	245.3M	226.5M	200.4M

Gross Profit Total Revenue

Allgens Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Net Income	Income Tax Expense	Total Other Income Expense Net	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation	Minority Interest
Depreciation And Amortization		0.34	0.67	0.52	0.46	0.45	0.55	-0.06	0.36	0.54	0.43	0.53	0.61	0.18	0.23	0.04	0.45	-0.72	0.37	0.43	-0.1	0.71	-0.67
Interest Expense	0.34		0.41	0.86	0.91	0.91	0.82	0.65	0.94	0.79	0.93	0.89	0.78	0.77	0.82	0.55	-0.37	-0.43	0.56	0.81	0.56	0.77	-0.73
Selling General Administrative	0.67	0.41		0.51	0.37	0.36	0.55	-0.31	0.31	0.42	0.33	0.44	0.7	0.02	0.09	0.03	0.31	-0.92	0.07	0.32	-0.39	0.62	-0.67
Selling And Marketing Expenses	0.52	0.86	0.51		0.88	0.87	0.99	0.43	0.79	0.96	0.81	0.92	0.95	0.56	0.64	0.21	-0.02	-0.66	0.75	0.87	0.29	0.94	-0.59
Total Revenue	0.46	0.91	0.37	0.88		1.0	0.89	0.73	0.97	0.9	0.97	0.99	0.79	0.87	0.92	0.62	-0.12	-0.45	0.71	0.85	0.58	0.82	-0.67
Gross Profit	0.45	0.91	0.36	0.87	1.0		0.88	0.74	0.97	0.89	0.97	0.98	0.77	0.88	0.92	0.63	-0.14	-0.43	0.7	0.84	0.59	0.81	-0.66
Other Operating Expenses	0.55	0.82	0.55	0.99	0.89	0.88		0.43	0.8	0.95	0.82	0.94	0.97	0.56	0.65	0.26	0.09	-0.67	0.7	0.82	0.23	0.93	-0.62
Operating Income	-0.06	0.65	-0.31	0.43	0.73	0.74	0.43		0.8	0.49	0.77	0.65	0.22	0.93	0.91	0.77	-0.45	0.27	0.51	0.54	0.91	0.29	-0.28
Ebit	0.36	0.94	0.31	0.79	0.97	0.97	0.8	0.8		0.77	1.0	0.93	0.7	0.91	0.94	0.75	-0.26	-0.3	0.55	0.74	0.65	0.7	-0.74
Research Development	0.54	0.79	0.42	0.96	0.9	0.89	0.95	0.49	0.77		0.79	0.94	0.87	0.62	0.7	0.21	0.02	-0.62	0.88	0.94	0.38	0.95	-0.48
Ebitda	0.43	0.93	0.33	0.81	0.97	0.97	0.82	0.77	1.0	0.79		0.94	0.73	0.89	0.93	0.72	-0.21	-0.34	0.56	0.75	0.62	0.73	-0.77
Cost Of Revenue	0.53	0.89	0.44	0.92	0.99	0.98	0.94	0.65	0.93	0.94	0.94		0.85	0.8	0.85	0.51	-0.01	-0.55	0.73	0.85	0.47	0.88	-0.68
Total Operating Expenses	0.61	0.78	0.7	0.95	0.79	0.77	0.97	0.22	0.7	0.87	0.73	0.85		0.39	0.48	0.15	0.16	-0.78	0.55	0.72	0.03	0.91	-0.69
Income Before Tax	0.18	0.77	0.02	0.56	0.87	0.88	0.56	0.93	0.91	0.62	0.89	0.8	0.39		0.99	0.85	-0.35	-0.03	0.55	0.67	0.84	0.49	-0.5
Net Income	0.23	0.82	0.09	0.64	0.92	0.92	0.65	0.91	0.94	0.7	0.93	0.85	0.48	0.99		0.81	-0.32	-0.12	0.61	0.73	0.81	0.57	-0.53
Income Tax Expense	0.04	0.55	0.03	0.21	0.62	0.63	0.26	0.77	0.75	0.21	0.72	0.51	0.15	0.85	0.81		-0.29	0.16	0.04	0.22	0.64	0.1	-0.55
Total Other Income Expense Net	0.45	-0.37	0.31	-0.02	-0.12	-0.14	0.09	-0.45	-0.26	0.02	-0.21	-0.01	0.16	-0.35	-0.32	-0.29		-0.4	-0.11	-0.27	-0.69	0.1	-0.06
Tax Provision	-0.72	-0.43	-0.92	-0.66	-0.45	-0.43	-0.67	0.27	-0.3	-0.62	-0.34	-0.55	-0.78	-0.03	-0.12	0.16	-0.4		-0.37	-0.52	0.35	-0.79	0.53
Net Interest Income	0.37	0.56	0.07	0.75	0.71	0.7	0.7	0.51	0.55	0.88	0.56	0.73	0.55	0.55	0.61	0.04	-0.11	-0.37		0.92	0.53	0.79	-0.1
Interest Income	0.43	0.81	0.32	0.87	0.85	0.84	0.82	0.54	0.74	0.94	0.75	0.85	0.72	0.67	0.73	0.22	-0.27	-0.52	0.92		0.56	0.89	-0.38
Net Income From Continuing Ops	-0.1	0.56	-0.39	0.29	0.58	0.59	0.23	0.91	0.65	0.38	0.62	0.47	0.03	0.84	0.81	0.64	-0.69	0.35	0.53	0.56		0.21	-0.14
Reconciled Depreciation	0.71	0.77	0.62	0.94	0.82	0.81	0.93	0.29	0.7	0.95	0.73	0.88	0.91	0.49	0.57	0.1	0.1	-0.79	0.79	0.89	0.21		-0.6
Minority Interest	-0.67	-0.73	-0.67	-0.59	-0.67	-0.66	-0.62	-0.28	-0.74	-0.48	-0.77	-0.68	-0.69	-0.5	-0.53	-0.55	-0.06	0.53	-0.1	-0.38	-0.14	-0.6

Click cells to compare fundamentals

Allgens Medical Account Relationship Matchups

Allgens Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	(707.8K)	9.7M	925.4K	10.5M	12.0M	12.6M
Interest Expense	1.0M	1.3M	3.4M	1.9M	3.1M	1.7M
Selling General Administrative	14.2M	4.4M	4.2M	8.8M	88.2M	92.6M
Selling And Marketing Expenses	15.6M	11.5M	23.1M	31.3M	36.0M	19.1M
Total Revenue	168.6M	183.8M	236.1M	245.3M	226.5M	200.4M
Gross Profit	139.7M	154.0M	201.5M	204.5M	187.2M	167.0M
Other Operating Expenses	106.5M	84.4M	115.3M	162.0M	186.3M	114.0M
Operating Income	74.4M	102.2M	134.9M	96.3M	32.9M	31.2M
Ebit	74.4M	102.2M	134.9M	96.3M	110.8M	87.1M
Research Development	22.5M	16.0M	33.2M	57.5M	45.5M	32.2M
Ebitda	73.7M	111.9M	135.8M	106.8M	122.8M	92.8M
Cost Of Revenue	28.9M	29.8M	34.6M	40.8M	39.2M	33.4M
Total Operating Expenses	77.6M	54.6M	80.7M	121.3M	193.6M	100.9M
Income Before Tax	74.6M	102.1M	132.0M	96.2M	49.1M	81.0M
Net Income	67.8M	88.9M	120.8M	95.2M	54.2M	76.0M
Income Tax Expense	10.4M	15.0M	14.0M	4.5M	5.2M	10.0M
Total Other Income Expense Net	104.6K	(110.4K)	(2.9M)	(114.8K)	(103.3K)	(108.5K)

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Allgens Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Allgens Historical Income Statement

About Allgens Income Statement Analysis

Allgens Medical Income Statement Chart

Total Revenue

Gross Profit

Allgens Medical income statement Correlations

Allgens Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Allgens Medical income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Allgens Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Ebitda	+ 1.0	Ebit
Other Operating Expenses	+ 0.99	Selling And Marketing Expenses
Cost Of Revenue	+ 0.99	Total Revenue
Net Income	+ 0.99	Income Before Tax
Cost Of Revenue	+ 0.98	Gross Profit

Tax Provision	- 0.92	Selling General Administrative
Reconciled Depreciation	- 0.79	Tax Provision
Tax Provision	- 0.78	Total Operating Expenses
Minority Interest	- 0.77	Ebitda
Minority Interest	- 0.74	Ebit
Minority Interest	- 0.73	Interest Expense